Electric Stimulation of the Eye to Improve Vision After Trauma

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)TraumaMultiple Sclerosis (MS)
Interventions
DEVICE

Transcorneal Electrical Stimulation

The clinical trial will investigate whether Transcorneal Electrical Stimulation delivered by the Okuvision Stimulation Set manufactured by Okuvision GmbH, Reutlingen, Germany, is a potentially effective therapy for the restoration and rehabilitation of vision loss as measured by improvements in visual acuity in the following three patient populations: patients with ocular trauma, patients with optic neuritis associated with multiple sclerosis and patients with Non-arteritic Anterior Ischemic Optic Neuropathy.

DEVICE

Sham

Sham

Trial Locations (1)

19107

Wills Eye Hospital, Philadelphia

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Wills Eye

OTHER

NCT02019927 - Electric Stimulation of the Eye to Improve Vision After Trauma | Biotech Hunter | Biotech Hunter